These primary data indicate a likely mechanism for thrombin-stimulated platelet aggregation and TLR4 expression and also provides a basis for further investigation of TLR4 modulation as a therapeutic strategy for coagulopathy and platelet disorders. This evidence concerns the gene TLR4 and blood platelet disease.